Bausch Health Companies Inc. (BHC): Price and Financial Metrics

Bausch Health Companies Inc. (BHC): $6.99

-0.13 (-1.83%)

POWR Rating

Component Grades








Add BHC to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals




#43 of 168

in industry

BHC Price/Volume Stats

Current price $6.99 52-week high $10.23
Prev. close $7.12 52-week low $4.00
Day low $6.97 Volume 1,148,956
Day high $7.15 Avg. volume 4,626,013
50-day MA $7.38 Dividend yield N/A
200-day MA $7.35 Market Cap 2.53B

BHC Stock Price Chart Interactive Chart >


  • Growth is the dimension where BHC ranks best; there it ranks ahead of 98.03% of US stocks.
  • The strongest trend for BHC is in Stability, which has been heading up over the past 179 days.
  • BHC's current lowest rank is in the Sentiment metric (where it is better than 1.95% of US stocks).

BHC Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for BHC is -10.19 -- better than just 1.78% of US stocks.
  • BHC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 0.74% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for BHC comes in at 57.64% -- higher than that of 96.69% of stocks in our set.
  • Stocks that are quantitatively similar to BHC, based on their financial statements, market capitalization, and price volatility, are CCLP, SMFL, MGI, WTI, and RGS.
  • BHC's SEC filings can be seen here. And to visit BAUSCH HEALTH COMPANIES INC's official web site, go to

BHC Valuation Summary

  • In comparison to the median Healthcare stock, BHC's price/earnings ratio is 135.68% lower, now standing at -8.6.
  • Over the past 243 months, BHC's price/earnings ratio has gone down 91.3.

Below are key valuation metrics over time for BHC.

Stock Date P/S P/B P/E EV/EBIT
BHC 2023-05-23 0.4 -3.8 -8.6 18.9
BHC 2023-05-22 0.4 -4.0 -9.0 19.1
BHC 2023-05-19 0.4 -3.8 -8.5 18.9
BHC 2023-05-18 0.4 -3.9 -8.7 19.0
BHC 2023-05-17 0.3 -3.4 -7.6 18.7
BHC 2023-05-16 0.3 -2.7 -6.1 18.2

BHC Growth Metrics

    Its year over year net cashflow from operations growth rate is now at -28.85%.
  • Its year over year price growth rate is now at -66.36%.
  • The 3 year revenue growth rate now stands at -0.9%.
BHC's revenue has moved down $474,000,000 over the prior 33 months.

The table below shows BHC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 8,127 -1,179 254
2022-06-30 8,192 648 43
2022-03-31 8,325 920 -407
2021-12-31 8,434 1,426 -948
2021-09-30 8,451 1,796 -1,170
2021-06-30 8,478 1,488 -1,287

BHC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BHC has a Quality Grade of C, ranking ahead of 53.93% of graded US stocks.
  • BHC's asset turnover comes in at 0.276 -- ranking 162nd of 680 Pharmaceutical Products stocks.
  • CCXI, NBY, and LLY are the stocks whose asset turnover ratios are most correlated with BHC.

The table below shows BHC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.276 0.714 -0.004
2021-03-31 0.259 0.714 0.006
2020-12-31 0.255 0.720 0.022
2020-09-30 0.250 0.721 -0.017
2020-06-30 0.252 0.725 -0.021
2020-03-31 0.265 0.729 -0.011

BHC Price Target

For more insight on analysts targets of BHC, see our BHC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $36.08 Average Broker Recommendation 1.62 (Moderate Buy)

Bausch Health Companies Inc. (BHC) Company Bio

Bausch Health Cos. Inc. (formerly) Valeant Pharmaceuticals is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter products, and medical devices, including contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices. The company was founded in 1983 and is based in Laval, Canada.

BHC Latest News Stream

Event/Time News Detail
Loading, please wait...

BHC Latest Social Stream

Loading social stream, please wait...

View Full BHC Social Stream

Latest BHC News From Around the Web

Below are the latest news stories about BAUSCH HEALTH COMPANIES INC that investors may wish to consider to help them evaluate BHC as an investment opportunity.

Why Bausch Health Companies Stock Is Tanking Today

Shares of Bausch Health Companies (NYSE: BHC) were down by 11.3% on sky-high volume as of 10:56 a.m. ET Tuesday morning. The big loss came after the drugmaker announced that the Food and Drug Administration (FDA) tentatively approved the abbreviated new drug application (ANDA) from Norwich Pharmaceuticals for the irritable bowel syndrome medication Xifaxan on June 2, 2023. In its June 2, 2023 letter, the FDA reportedly reaffirmed this later date as the benchmark for final approval.

Yahoo | June 6, 2023

Bausch Health Responds to Norwich's ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), and its gastroenterology business Salix Pharmaceuticals, understand that in a June 2, 2023, letter, the U.S. Food and Drug Administration (FDA) granted Norwich Pharmaceuticals Inc. Tentative Approval of its Abbreviated New Drug Application (ANDA) for XIFAXAN® (rifaximin) 550 mg. At the same time, the FDA confirmed in its Letter that it cannot grant Final Approval until Oct.

Yahoo | June 6, 2023

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease

Bausch Health Companies Inc. (NYSE/TSX: BHC) and its oral health care business, OraPharma, today announced its collaboration with World Series Champion, Alex Rodriguez, to launch a national awareness campaign about the prevalence and impact of gum disease. The Cover Your Bases campaign includes educational content about the disease and encourages patients to talk to their dentist about comprehensive treatment options. The campaign launch is timed to Oral Health Month recognized throughout June a

Yahoo | May 31, 2023

Top 10 Billionaire Stocks From 10 Billionaires

In this article, we will take a look at the top 10 billionaire stocks from 10 billionaires. To see more such companies, go directly to Top 5 Billionaire Stocks From 5 Billionaires. If you want to become a billionaire, do what billionaires do. This is perhaps the most truthful cliché statements that hold true irrespective […]

Yahoo | May 25, 2023

15 Best Stocks to Buy and Hold According to Billionaire Carl Icahn

In this article, we discuss 15 best stocks to buy and hold according to billionaire Carl Icahn. If you want to see more stocks in this selection, check out 5 Best Stocks to Buy and Hold According to Billionaire Carl Icahn. Carl Icahn, recognized for his expertise in the financial market, faced another blow on […]

Yahoo | May 19, 2023

Read More 'BHC' Stories Here

BHC Price Returns

1-mo 19.28%
3-mo -12.95%
6-mo -8.39%
1-year -22.33%
3-year -65.92%
5-year -72.90%
YTD 11.31%
2022 -77.25%
2021 32.74%
2020 -30.48%
2019 61.99%
2018 -11.12%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!